Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviana Rubino

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JCI Insight|November 2, 2021
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cellsMagdalena Hinterbrandner, Viviana Rubino, Carina Stoll, et al.
Cell Reports|December 24, 2025
Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8<sup>+</sup> T cell exhaustion in chronic myeloid leukemiaFrancesca Ronchi, Magdalena Hinterbrandner, Viviana Rubino, et al.
Cell Reports. Medicine|November 13, 2024
IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapyViviana Rubino, Michelle Hüppi, Sabine Höpner, et al.
Frontiers in Immunology|October 10, 2022
Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacitiesQuentin Haas, Nikita Markov, Lukas Muerner, et al.
Nature Communications|July 15, 2026
IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic LeukemiaHocine R Hocine, Undrakh Ganbaatar, Alfredo Amador-Molina, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JCI Insight|November 2, 2021
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cellsMagdalena Hinterbrandner, Viviana Rubino, Carina Stoll, et al.
Cell Reports|December 24, 2025
Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8<sup>+</sup> T cell exhaustion in chronic myeloid leukemiaFrancesca Ronchi, Magdalena Hinterbrandner, Viviana Rubino, et al.
Cell Reports. Medicine|November 13, 2024
IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapyViviana Rubino, Michelle Hüppi, Sabine Höpner, et al.
Frontiers in Immunology|October 10, 2022
Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacitiesQuentin Haas, Nikita Markov, Lukas Muerner, et al.
Nature Communications|July 15, 2026
IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic LeukemiaHocine R Hocine, Undrakh Ganbaatar, Alfredo Amador-Molina, et al.
Pageof 1